Upregulation of miR-191 promotes cell growth and invasion via targeting TIMP3 in prostate cancer.
CONCLUSION: This study demonstrated that miR-191 promoted the cell growth and invasion ability in prostate cancer through downregulating TIMP3 and might be a potential target for the biotherapy for PCa.
PMID: 29745091 [PubMed - in process]
Source: Journal of B.U.ON. - Category: Cancer & Oncology Tags: J BUON Source Type: research
More News: Benign Prostatic Hyperplasia | Cancer | Cancer & Oncology | Epithelial Cancer | Genetics | Prostate Cancer | Study